Medical Device | December 08, 2021
Venair showcases its Vena Flexip and Flexpure
The company plans to expand their capacity to meet the needs of pharma and biotech industries
The company plans to expand their capacity to meet the needs of pharma and biotech industries
This is the fourth facility from the company to receive this registration
It plans to add over 1000 employees over the next six months
SPARC will be eligible to receive an upfront payment, milestone payments and royalty on sales, in addition to 10% equity in Visiox
Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected
A Care network is a digital health network that connects healthcare stakeholders to deliver streamlined care with the patient at the centre of the experience
_256_384.jpg)
Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.
As part of the out-licensing deal with Tabuk, Biocon will develop and manufacture the products, and Tabuk will commercialise them
The investigational compound, GZR18, is a novel analogue of glucagon-like peptide-1 (GLP-1), an incretin hormone responsible for many glucoregulatory effects
Expanded EUA includes both treatment of patients with Covid-19 and post-exposure prophylaxis (PEP) in high-risk pediatric and infant patients
Subscribe To Our Newsletter & Stay Updated
